Scholarlink

<p>This review provides an update on advances during the past decade in our knowledge of the pharmacology and clinical use of memantine. It covers aspects related to preclinical research, such as new findings about the mechanism of action, and the efficacy of memantine in animal models of various diseases beyond dementia. In particular, new emerging indications since the publication of our latest review almost a decade ago were investigated. Where possible, preclinical findings were reinforced by data obtained in clinical studies in patients with Alzheimer’s disease, as well as in other indications reported by researchers who initiated off-label studies. This comprehensive narrative review demonstrates that memantine continues to show robust efficacy in its primary indication of Alzheimer's disease. However, while numerous potential new indications have emerged from preclinical studies, only a limited number show sufficient evidence to warrant further clinical investigation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Memantine: updates from the past decade and implications for future novel therapeutic applications

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月24日

查看全文
  • Wojciech Danysz,
  • Niels Hansen,
  • Jens Wiltfang,
  • Johannes Kornhuber,
  • Astrid Scheschonka,
  • Andreas Gravius

摘要

This review provides an update on advances during the past decade in our knowledge of the pharmacology and clinical use of memantine. It covers aspects related to preclinical research, such as new findings about the mechanism of action, and the efficacy of memantine in animal models of various diseases beyond dementia. In particular, new emerging indications since the publication of our latest review almost a decade ago were investigated. Where possible, preclinical findings were reinforced by data obtained in clinical studies in patients with Alzheimer’s disease, as well as in other indications reported by researchers who initiated off-label studies. This comprehensive narrative review demonstrates that memantine continues to show robust efficacy in its primary indication of Alzheimer's disease. However, while numerous potential new indications have emerged from preclinical studies, only a limited number show sufficient evidence to warrant further clinical investigation.